The global pharmaceuticals market is experiencing constant growth due to the global growth in life expectancy, as well as the growing incidence of chronic and infectious diseases. The steadily increasing demand for innovative drugs has thus triggered significant growth in R&D investments in the pharmaceutical industry. Leading global companies allocate around 20% of their turnover to R&D to maintain a competitive edge. The emergence of biopharmaceuticals has opened a new arena for drug discovery, and breakthroughs in the fields of proteomics and genomics have also enabled drug manufacturers to develop output-oriented effective drugs and therapies. We follow unique and extensive research methodologies for the delivery of market intelligence solutions across the healthcare ecosystem.